PAMP
OCUL icon

Polar Asset Management Partners’s Ocular Therapeutix OCUL Stock Holding History

Polar Asset Management Partners’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-56,670
Closed -$415K – 685
2025
Q1 		$415K Sell
56,670
-337,730
-86% -$2.6M 0.01% 339
2024
Q4 		$3.37M Sell
394,400
-98,500
-20% -$961K 0.04% 280
2024
Q3 		$4.29M Buy
+492,900
New +$4.06M 0.09% 213
2023
Q4 		– Sell
-263,763
Closed -$828K – 879
2023
Q3 		$828K Buy
+263,763
New +$1.08M 0.02% 472

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Polar Asset Management Partners's OCUL Position: Q2 2025 in Review

Polar Asset Management Partners sold out of Ocular Therapeutix (OCUL) in Q2 2025, closing a stake of 56,670 shares — an estimated $415K sold.

Polar Asset Management Partners first reported a position in OCUL in Q3 2023 and held it in 4 quarters. The position peaked at $4.29M in Q3 2024. 186 funds tracked by Wall St. Rank hold OCUL as of Q2 2025.

  • Polar Asset Management Partners reported no remaining Ocular Therapeutix position as of Q2 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 56,670 Ocular Therapeutix shares in Q2 2025, an estimated $415K.
  • Polar Asset Management Partners first reported a position in Ocular Therapeutix in Q3 2023 and held it in 4 quarters.
  • Polar Asset Management Partners's Ocular Therapeutix position peaked at $4.29M in Q3 2024.
  • 186 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2025.

Based on Polar Asset Management Partners's 13F filing for Q2 2025, filed 14 Aug 2025.